최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Tuberculosis and respiratory diseases : TRD = 결핵 및 호흡기 질환, v.61 no.5 = no.262, 2006년, pp.447 - 455
김유진 (가천의대 길병원 호흡기내과) , 김정호 (가천의대 길병원 호흡기내과) , 전효근 (가천의대 길병원 호흡기내과) , 김미경 (가천의대 길병원 호흡기내과) , 조용찬 (가천의대 길병원 호흡기내과) , 경선영 (가천의대 길병원 호흡기내과) , 안창혁 (가천의대 길병원 호흡기내과) , 이상표 (가천의대 길병원 호흡기내과) , 박정웅 (가천의대 길병원 호흡기내과) , 하승연 (가천의대 길병원 병리과) , 정성환 (가천의대 길병원 호흡기내과)
Background: MMPs and TIMPs are important factors for abnormal remodeling the pulmonary parenchyme in idiopathic interstitial pneumonia(IIP) This study evaluated the expression of MMPs and TIMPs in the tissue of IPF, NSIP and normal control subjects. Method: The MMP-2 and -9 activity in the lung tiss...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165: 277-304
Gross TJ, Hunninhake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517-25
Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am J Surg Pathol 1994;18:136-47
Leslie KO. Historical perspictive: a pathologic approach to the classification of idiopathic interstitial pneumonias . Chest 2005;128:513S-9S
Kim DS. idiopathic interstitial pneumonia. In: An CM, editor. Respiratory diseases. Seoul: Koonja publishing Inc;2004. p. 457-67
Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996;149:1241-56
Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992;7:120-5
Selman M, Ruiz V, Cabrea S, Segura L, Ramirez R, Barrios R, et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis: aprevailing nondegradative lung microenvironment- Am J Physiol Lung Cell Mol Physiol 2000;279:L562-74
Fukuda Y, Ishizake M, Kudoh S, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9, and tissue inhibitor of metalloproteinase- 2 in interstitial lung diseases. Lab invest 1998; 78:687-98
Madtes DK, Eliston AL, Kaback LA, Clark JG. Selective induction of tissue inhibitor of metalloproteinase- 1 in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2001;24:599-607
Choi KH, Lee HB, Jeong MY, Rhee YK, Chung MJ, Kwak YG,et al. The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia. Chest 2002;121:1478-85
Suga M, Iyonaga K, Okamoto T, Gushima Y, Miyakawa H, Akaike T, et al. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2000;162:1949-56
Kyung SY, Lim YH, An CH, Park JW, Jeong SH, Shin EK,et al. Immunohistochemical study of metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase- 1, -2 in idiopathic interstitial pneumonia. Korean J Med 2003;65:196-204
Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications fortherapy. Ann Intern Med 2001;134:136-51
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.